Canandaigua National Bank & Trust’s AstraZeneca AZN Stock Holding History

Canandaigua National Bank & Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.03M	Buy	11,040 +741	+7%	+$130K	0.18%	116
2025 Q3	$1.58M	Buy	10,299 +397	+4%	+$60.1K	0.14%	144
2025 Q2	$1.38M	Buy	9,902 +1,630	+20%	+$228K	0.13%	155
2025 Q1	$1.22M	Buy	8,272 +862	+12%	+$125K	0.12%	164
2024 Q4	$971K	Sell	7,410 -47	-0.6%	-$6.58K	0.1%	181
2024 Q3	$1.16M	Sell	7,457 -413	-5%	-$66.7K	0.11%	171
2024 Q2	$1.23M	Sell	7,870 -146	-2%	-$22K	0.13%	146
2024 Q1	$1.09M	Buy	+8,016	New	+$1.06M	0.16%	133
2018 Q3	–	Sell	-3,974	Closed	-$279K	–	346
2018 Q2	$279K	Buy	3,974 +57	+1%	+$4.1K	0.05%	249
2018 Q1	$274K	Buy	+3,917	New	+$271K	0.04%	299

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Canandaigua National Bank & Trust's AZN Position: Q4 2025 in Review

Canandaigua National Bank & Trust increased its AstraZeneca (AZN) stake by 7.2% in Q4 2025, buying an estimated $130K and bringing the position to 11,040 shares worth $2.03M. The position accounts for 0.18% of the portfolio, ranked #116.

Canandaigua National Bank & Trust first reported a position in AZN in Q1 2018 and has held it in 10 quarters since. 1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Canandaigua National Bank & Trust held 11,040 shares of AstraZeneca worth $2.03M as of Q4 2025.
Canandaigua National Bank & Trust bought 741 AstraZeneca shares in Q4 2025, an estimated $130K.
AstraZeneca made up 0.18% of Canandaigua National Bank & Trust's portfolio in Q4 2025, its #116 holding.
Canandaigua National Bank & Trust first reported a position in AstraZeneca in Q1 2018 and has held it in 10 quarters since.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Canandaigua National Bank & Trust's 13F filing for Q4 2025, filed 30 Jan 2026.